Cystic Fibrosis News Today Daily Digest

Cystic Fibrosis Weekly Update Contents: Moderna, Vertex Team Up to Develop Gene-editing Delivery Techniques For 7th Year, Bike 2 Breathe Hits Roads in Support of Those With CF Moderna, Vertex Team Up to Develop Gene-editing Delivery Techniques Sep 18, 2020 07:00 am | Forest Ray Moderna Therapeutics and Vertex Pharmaceuticals have entered a three-year research and licensing agreement aimed at developing gene-editing delivery techniques for the treatment of cystic fibrosis (CF). While Moderna will focus on ways to deliver gene-editing therapies to lung cells, Vertex will concentrate on other gene-editing components — and on subsequent preclinical and clinical development studies […] The post Moderna, Vertex Team Up to Develop Gene-editing Delivery Techniques appeared first on Cystic Fibrosis News Today. Read More For 7th Year, Bike 2 Breathe Hits Roads in Support of Those With CF Sep 17, 2020 07:00 am | Teresa Carvalho The 7th edition of Bike 2 Breathe, an initiative aiming to raise funds and awareness for cystic fibrosis (CF), is planned to start on Sept. 21 in Boston. The event was created by Jerry Cahill, a CF patient and ambassador for the Boomer Esiason Foundation (BEF), a nonprofit organization started by Boomer Esiason, a former American football […] The post For 7th Year, Bike 2 Breathe Hits Roads in Support of Those With CF appeared first on Cystic Fibrosis News Today. Read More Recent News Case Report Describes Unconventional Method for Delivering PERT in Premature CF Baby I’m Having Surgery (and Other Clickbait Headlines) Have Our Backs and Push Against Ableism With Us EMA Validates Application Seeking Expansion of Kaftrio Approval Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data